Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Robin Mukherjee
ResearcherPublications, citations & collaboration network
Robin Mukherjee is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 28 works, 2,888 citations, an h-index of 11 and an i10-index of 11.
28
Works
2,888
Citations
11
h-index
11
i10-index
IDs:OpenAlex
How has Robin Mukherjee's publication output changed over time?
ScholarIQpublication output · 2001–2010
Output grew0% over the shown period — from 1 works in 2001 to 1 in 2010.
1
1
2
1
2
1
1
1
20012002200420052006200820092010
What are the most-cited papers on Robin Mukherjee?
ScholarIQmost cited works
Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes
James A. de Lemos, Michael A. Blazing, Stephen D. Wiviott, Eldrin F. Lewis, Keith A.A. Fox, Harvey D. White, Jean‐Lucien Rouleau, Terje R. Pedersen, Laura H. Gardner, Robin Mukherjee, Karen E. Ramsey, Joanne Palmisano, David W. Bilheimer, Marc A. Pfeffer, Robert M. Califf, Eugene Braunwald, for the ASTEROID Investigators
JAMA. 20041,333 Citations
Selective Aldosterone Blockade with Eplerenone Reduces Albuminuria in Patients with Type 2 Diabetes
Murray Epstein, Gordon H. Williams, Myron H. Weinberger, Andrew Lewin, Scott Krause, Robin Mukherjee, Rajiv Patni, Bruce Beckerman
Clinical Journal of the American Society of Nephrology. 2006458 Citations
Eplerenone Reduces Mortality 30 Days After Randomization Following Acute Myocardial Infarction in Patients With Left Ventricular Systolic Dysfunction and Heart Failure
Bertram Pitt, Harvey D. White, José Carlos Nicolau, Felipe A. Martínez, Mihai Gheorghiade, Michael Aschermann, Dirk J. van Veldhuisen, Faı̈ez Zannad, Henry Krum, Robin Mukherjee, John Vincent
Journal of the American College of Cardiology. 2005387 CitationsOPEN ACCESS
Serum Potassium and Clinical Outcomes in the Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)
Bertram Pitt, George L. Bakris, Luís M. Ruilope, Lorenzo A. DiCarlo, Robin Mukherjee
Circulation. 2008236 CitationsOPEN ACCESS
Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: The ACUTE II study
Marc Cohen, Pierre Théroux, Steven Borzak, Martin J. Frey, Harvey D. White, W. Van Mieghem, Fred Senatore, Joy Lis, Robin Mukherjee, Kathy Harris, Frédérique Bigonzi
American Heart Journal. 2002160 Citations
Related on ScholarIQ
DBV Technologies (France)
Institution
Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes
Paper
Selective Aldosterone Blockade with Eplerenone Reduces Albuminuria in Patients with Type 2 Diabetes
Paper
Eplerenone Reduces Mortality 30 Days After Randomization Following Acute Myocardial Infarction in Patients With Left Ventricular Systolic Dysfunction and Heart Failure
Paper
Serum Potassium and Clinical Outcomes in the Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)
Paper
Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: The ACUTE II study
Paper